Clinical Trial Update: PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells [Phase 2]

View source ↗

Summary

Phase II trial assessing autologous mesenchymal stem cell therapy for osteonecrosis of the femoral head has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Osteonecrosis of the Femoral Head | Phase 2 | Status: COMPLETED